Public consultation on interim decision to amend the Poisons Standard in relation to psilocybine - ACMS JUNE 2025
Overview
Interim decisions regarding substances discussed at the expert advisory meetings.
This consultation is for the interim decision made in relation to psilocybine that was discussed at the June 2025 meeting of the Advisory Committee on Medicines Scheduling (ACMS).
Kindly note that the interim decision published below may differ from the initial proposal. Please read through the proposed interim decision which can be accessed through the link below and is available on the consultation page for your convenience.
Once you are familiar with the interim decision, please provide your comments and votes in relation to the interim decision.
The closing date for this consultation is close of business 3 July 2026. All submissions received by the deadline will be considered by the delegate before they make a final decision.
The interim decision under consultation is detailed in the Public notice of interim decision JUNE 2025 which can be accessed below:
Substance for which public comment is sought:
- PSILOCYBINE
Audiences
- Aboriginal and Torres Strait Islander People
- Academics
- Aged care professionals
- Aged care service providers
- Aged care workforce
- Biologicals
- BPRU staff
- Businesses
- Carers and guardians
- Commonwealth agencies
- Community groups
- Complementary medicines
- Contracted Service Providers
- Families
- General public
- Graduates
- Health professionals
- Health staff
- Health workforce
- HPRG (TGA) Staff
- Medical Devices & IVDs
- Men
- Non-government organisations
- Online and Publications staff
- Other
- Over-the-counter medicines
- Parents
- PCCD
- Prescription medicines
- Secretariat
- Seniors
- State government agencies
- Women
- Young people
Share
Share on Twitter Share on Facebook